Functional Selectivity of 6′-Guanidinonaltrindole (6′-GNTI) at κ-Opioid Receptors in Striatal Neurons
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional Selectivity of 6′-Guanidinonaltrindole (6′-GNTI) at κ-Opioid Receptors in Striatal Neurons
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 31, Pages 22387-22398
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-06-18
DOI
10.1074/jbc.m113.476234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening
- (2013) Ana Negri et al. Journal of Chemical Information and Modeling
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Ablation of Kappa-Opioid Receptors from Brain Dopamine Neurons has Anxiolytic-Like Effects and Enhances Cocaine-Induced Plasticity
- (2013) Ashlee Van't Veer et al. NEUROPSYCHOPHARMACOLOGY
- 6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment
- (2012) Marie-Laure Rives et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the human κ-opioid receptor in complex with JDTic
- (2012) Huixian Wu et al. NATURE
- A Simple Method for Quantifying Functional Selectivity and Agonist Bias
- (2011) Terry Kenakin et al. ACS Chemical Neuroscience
- Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in Rats
- (2011) Allison T. Knoll et al. BIOLOGICAL PSYCHIATRY
- Repeated Exposure to the κ-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward Sensitivity
- (2011) David N. Potter et al. BIOLOGICAL PSYCHIATRY
- Functional Selectivity at the -Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance
- (2011) K. M. Raehal et al. PHARMACOLOGICAL REVIEWS
- Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a -Arrestin2/Src/Akt Signaling Complex In Vivo
- (2010) C. L. Schmid et al. JOURNAL OF NEUROSCIENCE
- Quantification of Functional Selectivity at the Human 1A-Adrenoceptor
- (2010) B. A. Evans et al. MOLECULAR PHARMACOLOGY
- Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
- (2009) Benjamin B. Land et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action
- (2009) J. V. Aldrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kappa opioids promote the proliferation of astrocytes via Gβγ and β-arrestin 2-dependent MAPK-mediated pathways
- (2008) Gregory P. McLennan et al. JOURNAL OF NEUROCHEMISTRY
- Agonist-directed signaling of the serotonin 2A receptor depends on -arrestin-2 interactions in vivo
- (2008) C. L. Schmid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now